Literature DB >> 20370314

Brain tumor stem cells.

Thomas Palm1, Jens C Schwamborn.   

Abstract

Since the end of the 'no-new-neuron' theory, emerging evidence from multiple studies has supported the existence of stem cells in neurogenic areas of the adult brain. Along with this discovery, neural stem cells became candidate cells being at the origin of brain tumors. In fact, it has been demonstrated that molecular mechanisms controlling self-renewal and differentiation are shared between brain tumor stem cells and neural stem cells and that corruption of genes implicated in these pathways can direct tumor growth. In this regard, future anticancer approaches could be inspired by uncovering such redundancies and setting up treatments leading to exhaustion of the cancer stem cell pool. However, deleterious effects on (normal) neural stem cells should be minimized. Such therapeutic models underline the importance to study the cellular mechanisms implicated in fate decisions of neural stem cells and the oncogenic derivation of adult brain cells. In this review, we discuss the putative origins of brain tumor stem cells and their possible implications on future therapies.

Entities:  

Mesh:

Year:  2010        PMID: 20370314     DOI: 10.1515/BC.2010.059

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  4 in total

Review 1.  Effects of Lovastatin on Brain Cancer Cells.

Authors:  Efosa Amadasu; Richard Kang; Ahsan Usmani; Cesario V Borlongan
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

2.  MicroRNA-107 inhibits U87 glioma stem cells growth and invasion.

Authors:  Lei Chen; Xiang-rong Chen; Fan-fan Chen; Yi Liu; Peng Li; Run Zhang; Ke Yan; Yong-jun Yi; Zhi-min Xu; Xiao-Dan Jiang
Journal:  Cell Mol Neurobiol       Date:  2013-04-10       Impact factor: 5.046

3.  MicroRNA-9 reveals regional diversity of neural progenitors along the anterior-posterior axis.

Authors:  Boyan Bonev; Angela Pisco; Nancy Papalopulu
Journal:  Dev Cell       Date:  2011-01-18       Impact factor: 12.270

4.  CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4.

Authors:  Diana Aguilar-Morante; Jose A Morales-Garcia; Angel Santos; Ana Perez-Castillo
Journal:  Oncotarget       Date:  2015-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.